Hanaphenobarbital Tablet

Adult dosage

(Oral: Tablets) ○ Adults 1) Insomnia: Administer 30-200㎎ of phenobarbital orally at bedtime. 2) Sedation and epilepsy: Administer 30-200㎎ of this drug in 1-4 divided doses. (Injection) ○ Adults 1) Sedation and epilepsy: Administer 50-200㎎ of phenobarbital sodium subcutaneously or intramuscularly in 1-2 doses daily. 2) Status epilepticus: Administer 200-600㎎ of this drug by intravenous injection. The dose may be adjusted appropriately according to age and symptoms.

Children's dosage

(Oral: Tablets) ○ Children - Epilepsy: Administer 3-6㎎ per kg of body weight of this drug. The dose may be adjusted appropriately according to age and symptoms.

This drug is a sleep sedative, and it can be very dangerous to drive or engage in other complex behaviors while still being under its effects. Taking this drug with alcohol or other central nervous system depressants increases these risks, so caution is required. Additionally, during the use of this drug, vascular swelling may occur in the tongue, vocal cords, or larynx, and anaphylactic reactions such as difficulty breathing, nausea, or vomiting may occur, which may require emergency treatment. Patients experiencing such symptoms should not take this drug again. Patients with severe liver or kidney impairment, respiratory disorders, acute intermittent porphyria, hypersensitivity to barbiturates, pregnant women or women who may become pregnant, patients with anaphylactic shock, those with central nervous system depression or alcohol dependence, and patients with lactose intolerance should not be administered this drug. Careful administration is required for the elderly, frail patients, those with sequelae from head trauma or organic brain disorders, patients with drug hypersensitivity, those with a history of drug dependence, patients with severe neuroses, patients with hypothyroidism, and patients with cardiac disorders. This drug may lead to dependence with long-term use, and sudden withdrawal may result in withdrawal symptoms such as anxiety, insomnia, seizures, or hallucinations, so it should be tapered off slowly. Various side effects such as skin rash, respiratory depression, hematologic abnormalities, liver function abnormalities, neuropsychiatric symptoms, renal and gastrointestinal abnormalities, and hypersensitivity reactions may occur and should be monitored closely. After taking this drug, one should avoid driving or operating dangerous machinery, and should not use it in conjunction with alcohol or other central nervous system depressants. Especially for women of childbearing age, pregnancy should be confirmed before taking this drug, and effective contraception should be used during the therapy period and for 2 months after the last dose. This drug poses a risk of causing congenital malformations or neurodevelopmental disorders in the fetus, so use during pregnancy must be approached with caution. In case of overdose, central nervous system and cardiovascular depression may occur, which can lead to a coma in severe cases, requiring immediate emergency treatment. Respiratory management, gastric lavage, administration of activated charcoal, urine alkalinization, and diuretics may be included in treatment methods. Finally, this drug should be stored out of reach of children and kept in its original container to prevent improper use or deterioration of quality.

Sleep driving, combined behaviors while fully unsober after taking a sedative, tongue vascular swelling, laryngeal vascular swelling, pharyngeal vascular swelling, shortness of breath, throat obstruction, nausea, vomiting, anaphylactic reaction, anxiety, insomnia, seizures, nausea, hallucinations, delusions, agitation, confusion, depressive state, rash, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, exfoliative dermatitis, respiratory depression, thrombocytopenia, macrocytic anemia, hypocalcemia, aplastic anemia, jaundice, ALT elevation, AST elevation, γ-GTP elevation, porphyria, drowsiness, fixed postural inability, dizziness, headache, nonsensical talk, stupor, heaviness, speech disorder, abnormal perception, ataxia, cognitive dysfunction, hematoporphyrinuria, proteinuria, loss of appetite, erythema multiforme-like rash, measles-like rash, toxic erythema-like rash, delayed severe hypersensitivity symptoms, rickets, osteomalacia, dental enamel hypoplasia, hypothyroidism, bradycardia, hypotension, shock, arrhythmia, double vision, nystagmus, granulocytopenia, fever, arthralgia, drowsiness, nystagmus, ataxia, comatose state, respiratory depression, weakened pulse, lowered body temperature

This drug should be stored in a tightly sealed container that does not allow air in, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a longer period.

Appearance

Round white tablet

Package unit

100 tablets/bottle